What are the side effects of BIKTARVY 50 MG/200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA?

This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems . For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme

Can BIKTARVY 50 MG/200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA be used during pregnancy?

( AHT ) For the active ingredient bictegravir + emtricitabine + tenofovir alafenamide You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What precautions should be taken with BIKTARVY 50 MG/200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA?

• Caution should be exercised in patients with history of liver problems, including HBV infection, bone problems or kidney problems, any allergy, during pregnancy and breastfeeding. • It may cause dizziness, do not drive a car or operate machinery while taking this medication. • It does not stop the spread of HIV or HBV to others through blood or sexual contact.

Who manufactures BIKTARVY 50 MG/200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA?

Gilead Sciences Ireland Unlimited Company (ES)

OTC

BIKTARVY 50 MG/200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

200 mg/25 mg/50 mg, COMPRIMIDO RECUBIERTO CON PELÍCULA

INN: BICTEGRAVIR SODIO, EMTRICITABINA, TENOFOVIR ALAFENAMIDA FUMARATO

Data updated: 2026-04-15

Available in:

🇨🇿🇩🇪🇬🇧🇪🇸🇫🇷🇵🇹🇸🇰

Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Dosage

200 mg/25 mg/50 mg

Route

VÍA ORAL

Storage

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.